Robbins & Myers 8-K Robbins & Myers Reports Third Quarter Fiscal 2007 Results

Exhibit 99.1

Investor Relations
+1 (937) 222-2610

ROBBINS & MYERS REPORTS
THIRD QUARTER FISCAL 2007 RESULTS

All Segments Report Sales Growth and Significant Improvements in Profitability

DAYTON, OHIO, June 28, 2007...Robbins & Myers, Inc. (NYSE:RBN)today reported diluted net earnings per share (DEPS) of $0.77 for its third fiscal quarter ended May 31, 2007. In its prior year third quarter, the Company posted a per share loss of $0.01, which included $5 million of net special items. Net earnings per share increased as a result of higher sales, an improved operating cost structure, lower financing costs, and reduced special charges. Current year third quarter results included approximately $0.06 of DEPS benefit from a better than expected effective tax rate, which resulted primarily from improved utilization of net operating loss carry-forward benefits.

The Company reported third quarter 2007 sales of $171 million and orders of $186 million, $18 million and $5 million higher, respectively, than in the prior year third quarter. Excluding sales and orders from divested product lines, sales increased 17%, and orders increased 7%. The Company divested certain product lines from its Romaco business group in March 2006, November 2006 and March 2007.

“We are pleased to report our fourth consecutive quarter of year-over-year sales and order growth and finish the third quarter with record backlog of $212 million,” said Peter C. Wallace, President and Chief Executive Officer of Robbins & Myers, Inc. “End markets remain very active, new product and application initiatives are contributing to our success, and we continue to develop our customer-facing capabilities to identify and execute new avenues of profitable growth.”

The Company achieved earnings before interest, taxes and minority interest (EBIT) of $23 million in the third quarter of 2007, which included $0.4 million of restructuring costs in its Romaco segment. Excluding special items in both the current and prior periods, adjusted EBIT margins increased 630 basis points over the prior year to 13.7%. The improvement in adjusted EBIT margins was driven primarily by higher sales volume and savings from completed restructuring programs, as well as a favorable sales mix within the Fluid Management segment that is expected to moderate in the fourth quarter. The Company also reported $27 million of EBITDA in its current year third quarter.

“We have made great progress transforming our Company over the past two years,” said Peter C. Wallace, President and Chief Executive Officer of Robbins & Myers, Inc. “Through product line dispositions and other restructuring efforts, our Romaco business is now profitable and focused on growth in its core packaging and processing markets. We are benefiting from our Process Solutions business’ improved cost structure with higher margins and increasing sales. Our Fluid Management business continues to take advantage of healthy end markets and leverage functional capabilities across the group to increase sales and profits. We are well positioned to produce record results in 2007.”

The Company announced that it increased its fiscal 2007 DEPS guidance from $2.20 — $2.40 to $2.60 - $2.70 and established fourth quarter diluted earnings per share guidance of $0.75 — $0.85.

Third Quarter Results by Segment

All comparisons are made against the comparable year-ago period unless otherwise stated.

TheFluid Management segment reported $74.4 million of sales in the third quarter of 2007, 21% higher than in the prior year period, and orders increased 15% to $75.1 million, due primarily to favorable energy market conditions. As a result of increased sales and better utilization of facilities, as well as a favorable product mix that is expected to moderate in the fourth quarter, EBIT grew 62% to $20.6 million in the third quarter, and EBIT margins improved 710 basis points to 27.7%.

The Company’sProcess Solutions segment third quarter sales increased 16% to $66.4 million, and orders grew 9% to $78.0 million as a result of favorable global chemical and pharmaceutical market conditions, sales from newer applications and currency exchange rate changes. Third quarter 2007 EBIT improved to $5.3 million. Excluding $3.5 million of restructuring costs incurred in the prior year third quarter, adjusted EBIT margins expanded by 280 basis points to 7.9% as a result of sales growth and benefits from prior year restructuring.

Romaco segment third quarter fiscal 2007 sales of $30.6 million and orders of $33.0 million are lower than in the prior year quarter due to the sale of four product lines since March 2006, including the disposition of a small product line in the third quarter of 2007. Excluding these divested product lines, third quarter sales increased 11% year-over-year and orders decreased 12% as a result of unusually strong orders in the prior year. The segment earned $1.2 million of EBIT in the third quarter of 2007 versus a loss of $1.4 million in the comparable prior year period. Excluding special items from both periods, adjusted EBIT margins improved 430 basis points to 5.2%.

Conference Call to Be Held at 10:00 AM (Eastern) Tomorrow

A conference call to discuss these results has been scheduled for 10:00 AM ET on Friday, June 29, 2007. The call can be accessed via webcast or via telephone by dialing (866) 713-8395 (US/Canada) or +1 (617) 597-5309 (outside US/Canada) and using access code 69982876. Webcast information and conference call materials will be made available on the Company’s website (www.robn.com, “Investor Information” section) prior to the start of the call. Telephonic replays will be available for one week by calling (888) 286-8010 (US/Canada) or +1 (617) 801-6888 (outside US/Canada) and using the access code 48695343.

About Robbins & Myers

Robbins & Myers, Inc. is a leading global supplier of highly-engineered, application-critical equipment and systems to the global energy, chemical, pharmaceutical and industrial markets.

In this release the Company refers to various non-GAAP measures, including EBIT and EBITDA (earnings before interest, taxes, depreciation and amortization). The Company believes these measures are helpful to investors in assessing its performance. The

reconciliation of EBIT to net income is presented in the condensed consolidated income statement below. The reconciliation of EBITDA to net income is as follows:

(Millions)

	Third Quarter Ended
	May 31, 2007
Net income	$	13.2
Interest expense		1.5
Income taxes		8.0
Depreciation and amortization		4.0
EBITDA	$	26.7

In addition to historical information, this release contains certain statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding the intent, belief or current expectations regarding the matters discussed or incorporated by reference in this document (including statements as to “beliefs,” “expectations,” “anticipations,” “intentions” or similar words) and all statements which are not statements of historical fact. Such forward-looking statements, together with other statements that are not historical, are based on management’s current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated. The most significant of these risks and uncertainties are described in the Company’s Form 10-K, and Form 10-Q reports filed with the Securities and Exchange Commission and include, but are not limited to: a significant decline in capital expenditures in the specialty chemical and pharmaceutical industries; a major decline in oil and natural gas prices; changes in international economic and political conditions and currency fluctuations between the U.S. dollar and other currencies; the impacts of Sarbanes-Oxley section 404 procedures; work stoppages related to union negotiations; customer order cancellations; the ability of the Company to comply with the financial covenants and other provisions of its financing arrangements; the ability of the Company to realize the benefits of its restructuring program in its Romaco and Process Solutions Segments, including the receipt of cash proceeds from the sale of excess facilities; events or circumstances which result in an impairment of assets, including but not limited to, goodwill; the potential impact of U.S. and foreign legislation, government regulations, and other government action, including those relating to export and import of products and materials, and changes in the interpretation and application of such laws and regulations; the outcome of audit, compliance, administrative or investigatory reviews; and general economic conditions that can affect demand in the process industries. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as otherwise required by law, the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

[Financial Tables]

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
 (Unaudited)

(in thousands)	May 31, 2007		August 31, 2006
ASSETS
Current Assets:
Cash and cash equivalents	$	62,459	$	48,365
Accounts receivable		139,963		124,569
Inventories		109,186		94,990
Other current assets		7,606		6,260
Deferred taxes		10,274		9,937
Total Current Assets		329,488		284,121
Goodwill & Other Intangible Assets		281,797		273,834
Other Assets		13,066		14,381
Property, Plant & Equipment		128,902		127,030
	$	753,253	$	699,366
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	58,351	$	62,749
Accrued expenses		109,461		102,327
Current portion of long-term debt		73,660		744
Total Current Liabilities		241,472		165,820
Long-Term Debt — Less Current Portion		30,000		104,787
Other Long-Term Liabilities		88,951		89,337
Shareholders’ Equity		392,830		339,422
	$	753,253	$	699,366

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENT
 (Unaudited)

	Three Months Ended					Nine Months Ended
	May 31,		May 31,			May 31,			May 31,
(in thousands, except per share data)	2007		2006			2007			2006
Sales	$	171,428	$	153,243		$	488,359		$	442,199
Cost of sales		110,013		100,438			318,232			292,823
Gross profit		61,415		52,805			170,127			149,376
SG&A expenses		37,628		40,779			113,210			122,718
Amortization expense		366		625			1,118			1,766
Goodwill impairment charge		0		9,174			0			39,174
Other		421		(3,947	)		(2,158	)		(2,707	)
Income (loss) before interest and income taxes		23,000		6,174			57,957			(11,575	)
Interest expense		1,465		3,125			4,350			10,324
Income (loss) before income taxes and minority interest		21,535		3,049			53,607			(21,899	)
Income tax expense		7,952		2,846			20,903			5,365
Minority interest		335		278			911			1,343
Net income (loss)	$	13,248		($75	)	$	31,793			($28,607	)
Net income (loss) per share:
Basic	$	0.78		($0.01	)	$	1.87			($1.94	)
Diluted	$	0.77		($0.01	)	$	1.86			($1.94	)
Weighted Average Common Shares Outstanding:
Basic		17,085		14,784			16,993			14,743
Diluted		17,205		16,592			17,103			16,541
Orders	$	186,053	$	180,923		$	531,144		$	494,159
Backlog	$	212,151	$	162,972		$	212,151		$	162,972

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED BUSINESS SEGMENT INFORMATION
 (Unaudited)

	Three Months Ended						Nine Months Ended
	May 31,			May 31,			May 31,			May 31,
(in thousands)	2007			2006			2007			2006
Sales
Fluid Management	$	74,418		$	61,675		$	208,236		$	171,934
Process Solutions		66,442			57,138			194,311			164,172
Romaco		30,568	(2)		34,430	(2)		85,812	(2)		106,093	(2)
Total	$	171,428		$	153,243		$	488,359		$	442,199
Income Before Interest and Income Taxes (EBIT)
Fluid Management	$	20,585		$	12,701		$	53,010		$	36,886
Process Solutions		5,261			(617	)(1)		21,413	(1)		2,690	(1)
Romaco		1,163	(2)		(1,388	)(2)		(4,109	)(2)		(37,457	)(2)
Corporate and Eliminations		(4,009	)		(4,522	)		(12,357	)		(13,694	)
Total	$	23,000		$	6,174		$	57,957			($11,575	)
Depreciation and Amortization
Fluid Management	$	1,698		$	1,802		$	5,116		$	5,356
Process Solutions		1,647			1,691			4,855			5,047
Romaco		472			731			1,507			2,228
Corporate and Eliminations		166			422			682			1,205
Total	$	3,983		$	4,646		$	12,160		$	13,836
Orders
Fluid Management	$	75,067		$	65,585		$	221,535		$	179,333
Process Solutions		78,018			71,505			212,969			191,515
Romaco		32,968			43,833			96,640			123,311
Total	$	186,053		$	180,923		$	531,144		$	494,159
Backlog
Fluid Management	$	46,597		$	29,013		$	46,597		$	29,013
Process Solutions		107,091			84,455			107,091			84,455
Romaco		58,463			49,504			58,463			49,504
Total	$	212,151		$	162,972		$	212,151		$	162,972

(1)

The nine month period ended May 31, 2007 includes a $5,036,000 gain on the sale of land and buildings. The three and nine month periods ended May 31, 2006 include costs of $3,516,000 and $4,653,000, respectively, related to restructuring of our Process Solutions businesses and closure of an Edlon facility. The nine month period ended May 31, 2006 also includes a gain of $1,800,000 related to the sale of land and buildings in China.

(2)

The three month periods ended May 31, 2007 and 2006 include costs of $421,000 and $60,000, respectively related to restructuring our Romaco business. Also, in the three month period ended May 31, 2007 we disposed of an unprofitable brand for approximately its book value. The costs of the Romaco restructuring included in the nine month periods ended May 31, 2007 and 2006 were $2,878,000 (including a $1,060,000 loss on the sale of another unprofitable brand in the second quarter of 2007) and $1,963,000, respectively. In the third quarter of fiscal 2006 we also sold two profitable Romaco brands at a gain of $7,523,000. The three and nine month periods ended May 31, 2006 also include goodwill impairment charges of $9,174,000 and $39,174,000, respectively. Ficsal 2006 also includes sales and EBIT of disposed brands.